BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 16782199)

  • 1. Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour.
    O'Tuathaigh CM; Babovic D; O'Meara G; Clifford JJ; Croke DT; Waddington JL
    Neurosci Biobehav Rev; 2007; 31(1):60-78. PubMed ID: 16782199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant models for genes associated with schizophrenia.
    Desbonnet L; Waddington JL; O'Tuathaigh CM
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):308-12. PubMed ID: 19143653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia: genes at last?
    Owen MJ; Craddock N; O'Donovan MC
    Trends Genet; 2005 Sep; 21(9):518-25. PubMed ID: 16009449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia.
    Pletnikov MV; Ayhan Y; Nikolskaia O; Xu Y; Ovanesov MV; Huang H; Mori S; Moran TH; Ross CA
    Mol Psychiatry; 2008 Feb; 13(2):173-86, 115. PubMed ID: 17848917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene models of schizophrenia: DISC1 mouse models.
    Jaaro-Peled H
    Prog Brain Res; 2009; 179():75-86. PubMed ID: 20302820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.
    Harrison PJ; Weinberger DR
    Mol Psychiatry; 2005 Jan; 10(1):40-68; image 5. PubMed ID: 15263907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of thermal nociceptive behaviour in mice mutant for the schizophrenia-associated genes NRG1, COMT and DISC1.
    Walsh J; Tighe O; Lai D; Harvey R; Karayiorgou M; Gogos JA; Waddington JL; O'Tuathaigh CM
    Brain Res; 2010 Aug; 1348():114-9. PubMed ID: 20561508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1.
    O'Tuathaigh CM; O'Connor AM; O'Sullivan GJ; Lai D; Harvey R; Croke DT; Waddington JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):462-6. PubMed ID: 17980471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.
    O'Tuathaigh CM; Babovic D; O'Sullivan GJ; Clifford JJ; Tighe O; Croke DT; Harvey R; Waddington JL
    Neuroscience; 2007 Jun; 147(1):18-27. PubMed ID: 17512671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia.
    Karl T; Duffy L; Scimone A; Harvey RP; Schofield PR
    Genes Brain Behav; 2007 Oct; 6(7):677-87. PubMed ID: 17309661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia susceptibility genes: emergence of positional candidates and future directions.
    Gogos JA; Gerber DJ
    Trends Pharmacol Sci; 2006 Apr; 27(4):226-33. PubMed ID: 16530856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
    Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia.
    Ikeda M; Hikita T; Taya S; Uraguchi-Asaki J; Toyo-oka K; Wynshaw-Boris A; Ujike H; Inada T; Takao K; Miyakawa T; Ozaki N; Kaibuchi K; Iwata N
    Hum Mol Genet; 2008 Oct; 17(20):3212-22. PubMed ID: 18658164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia.
    Wood LS; Pickering EH; Dechairo BM
    Biol Psychiatry; 2007 May; 61(10):1195-9. PubMed ID: 17055463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
    Prasad SE; Howley S; Murphy KC
    Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain.
    Wood JD; Bonath F; Kumar S; Ross CA; Cunliffe VT
    Hum Mol Genet; 2009 Feb; 18(3):391-404. PubMed ID: 18996920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible and conditional transgenic mouse models of schizophrenia.
    Pletnikov MV
    Prog Brain Res; 2009; 179():35-47. PubMed ID: 20302816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic mechanisms of psychosis: in vivo and postmortem genomics.
    Weinberger DR
    Clin Ther; 2005; 27 Suppl A():S8-15. PubMed ID: 16198200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse models of genetic effects on cognition: relevance to schizophrenia.
    Papaleo F; Lipska BK; Weinberger DR
    Neuropharmacology; 2012 Mar; 62(3):1204-20. PubMed ID: 21557953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the genetics of schizophrenia.
    O'Donovan MC; Williams NM; Owen MJ
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R125-33. PubMed ID: 12952866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.